IntroductionDendritic cells (DCs) are the most powerful antigen-presenting cells (APCs), with unique features in initiating antigen (Ag)-specific immune responses, activating both naive CD4 ϩ and CD8 ϩ T lymphocytes. 1 To do so, DCs undergo a series of developmental changes in a process known as "maturation." Immature DCs are endowed with potent ability to capture Ags but are inefficient at presenting the processed Ags on their MHC class II (MHC-II) molecules, and thus are poor T-cell stimulators. Upon contact with microbial products or inflammatory cytokines, DCs are induced to mature and become highly efficient at presenting Ags and activating T cells while exhibiting reduced capacity for uptake and processing of newly encountered antigens. 2 Immature DCs are tuned to sample their environment and to capture any foreign particle. To accomplish this task, DCs use at least 2 mechanisms to internalize soluble proteins, fluid-phase macropinocytosis or receptor-mediated endocytosis by members of different receptor families. 3 The most prominent member of these membrane-bound proteins is the mannose receptor (MR). The MR acts as a pattern recognition molecule that enables efficient capture of mannosylated or fucosylated antigens, like dextran (DX), and is the main effector of receptor-mediated endocytosis. [4][5][6] In this regard, MRmediated uptake of Ags has been shown to potently enhance MHC-II-restricted Ag presentation in both human and mouse DCs. 7,8 In mouse spleen, distinct DC subtypes, including CD8␣ ϩ and CD8␣ Ϫ DCs, can be identified with diverse localization, ontogeny, and nature of immune response induced, but with a common ability to capture, process, and present soluble antigens. 9 Lymphoid organ-resident DCs have been generally considered as mature DCs based on high-level expression of costimulatory molecules as well as for their exceptional ability to stimulate both allogeneic T cells and Ag-specific naive T cells. 9,10 However, a number of reports have shown that spleen DC (s-DCs) can efficiently endocytose Ags, both in vitro and in vivo, suggesting that these cells may also exhibit features of immature DCs. [11][12][13][14][15] A recent study has clarified this controversy by showing that most subsets of lymphoid organ DCs, including CD8␣ ϩ and CD8␣ Ϫ s-DCs, are phenotypically and functionally immature in the steady state and are induced to mature only upon stimulation in vitro or in vivo. 16,17 This immature feature of s-DCs is particularly relevant for the maintenance of peripheral tolerance and allows DCs to promptly capture blood-circulating antigens and to mature in situ. 18 Interferon consensus sequence-binding protein (ICSBP), also known as interferon regulatory factor 8 (IRF-8), is a transcription factor that plays a prominent role in myeloid cell development as well as in the immune response to various infectious agents. 19,20 We and others have recently demonstrated that ICSBP is critically required for the normal development of defined DC populations. ICSBP Ϫ/Ϫ mice lack plasmacytoid DCs...